Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 472

    1.

    Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses.

    Nora T, Bouchonnet F, Labrosse B, Charpentier C, Mammano F, Clavel F, Hance AJ.

    Retrovirology. 2008 Feb 29;5:23.

    PMID:
    18312646
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Phenotypic studies on recombinant human immunodeficiency virus type 1 (HIV-1) containing CRF01_AE env gene derived from HIV-1-infected patient, residing in central Thailand.

    Utachee P, Jinnopat P, Isarangkura-Na-Ayuthaya P, de Silva UC, Nakamura S, Siripanyaphinyo U, Wichukchinda N, Tokunaga K, Yasunaga T, Sawanpanyalert P, Ikuta K, Auwanit W, Kameoka M.

    Microbes Infect. 2009 Mar;11(3):334-43. Epub 2008 Dec 27.

    PMID:
    19136072
    [PubMed - indexed for MEDLINE]
    3.

    Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates.

    Baatz F, Nijhuis M, Lemaire M, Riedijk M, Wensing AM, Servais JY, van Ham PM, Hoepelman AI, Koopmans PP, Sprenger HG, Devaux C, Schmit JC, Perez Bercoff D.

    PLoS One. 2011;6(7):e21535. Epub 2011 Jul 8.

    PMID:
    21760896
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.

    Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF.

    AIDS. 2008 Jul 31;22(12):1425-31.

    PMID:
    18614865
    [PubMed - indexed for MEDLINE]
    5.

    The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.

    Rossi F, Querido B, Nimmagadda M, Cocklin S, Navas-Martín S, Martín-García J.

    Retrovirology. 2008 Oct 6;5:89.

    PMID:
    18837996
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patients.

    Labrosse B, Morand-Joubert L, Goubard A, Rochas S, Labernardière JL, Pacanowski J, Meynard JL, Hance AJ, Clavel F, Mammano F.

    J Virol. 2006 Sep;80(17):8807-19.

    PMID:
    16912327
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors.

    Ray N, Harrison JE, Blackburn LA, Martin JN, Deeks SG, Doms RW.

    J Virol. 2007 Apr;81(7):3240-50. Epub 2007 Jan 24.

    PMID:
    17251281
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors.

    Brown RJ, Peters PJ, Caron C, Gonzalez-Perez MP, Stones L, Ankghuambom C, Pondei K, McClure CP, Alemnji G, Taylor S, Sharp PM, Clapham PR, Ball JK.

    J Virol. 2011 Jun;85(12):6024-37. Epub 2011 Apr 6.

    PMID:
    21471230
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Enfuvirtide resistance mutations: impact on human immunodeficiency virus envelope function, entry inhibitor sensitivity, and virus neutralization.

    Reeves JD, Lee FH, Miamidian JL, Jabara CB, Juntilla MM, Doms RW.

    J Virol. 2005 Apr;79(8):4991-9.

    PMID:
    15795284
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity.

    Skrabal K, Saragosti S, Labernardière JL, Barin F, Clavel F, Mammano F.

    J Virol. 2005 Sep;79(18):11848-57.

    PMID:
    16140761
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type.

    Matsuoka S, Dam E, Lecossier D, Clavel F, Hance AJ.

    Retrovirology. 2009 Mar 2;6:21.

    PMID:
    19254360
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection.

    Dash PK, Siddappa NB, Mangaiarkarasi A, Mahendarkar AV, Roshan P, Anand KK, Mahadevan A, Satishchandra P, Shankar SK, Prasad VR, Ranga U.

    Retrovirology. 2008 Mar 7;5:25.

    PMID:
    18328091
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeeding.

    Rainwater SM, Wu X, Nduati R, Nedellec R, Mosier D, John-Stewart G, Mbori-Ngacha D, Overbaugh J.

    Curr HIV Res. 2007 Mar;5(2):189-97.

    PMID:
    17346133
    [PubMed - indexed for MEDLINE]
    14.

    Comparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07/08_BC env molecular clones isolated from infections in China.

    Wang S, Nie J, Wang Y.

    Virus Res. 2011 Jan;155(1):137-46. Epub 2010 Sep 25.

    PMID:
    20875470
    [PubMed - indexed for MEDLINE]
    15.

    Characteristics of the env genes of HIV type 1 quasispecies in long-term nonprogressors with broadly neutralizing antibodies.

    Braibant M, Agut H, Rouzioux C, Costagliola D, Autran B, Barin F.

    J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):274-84.

    PMID:
    18197126
    [PubMed - indexed for MEDLINE]
    16.

    Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa.

    Li M, Salazar-Gonzalez JF, Derdeyn CA, Morris L, Williamson C, Robinson JE, Decker JM, Li Y, Salazar MG, Polonis VR, Mlisana K, Karim SA, Hong K, Greene KM, Bilska M, Zhou J, Allen S, Chomba E, Mulenga J, Vwalika C, Gao F, Zhang M, Korber BT, Hunter E, Hahn BH, Montefiori DC.

    J Virol. 2006 Dec;80(23):11776-90. Epub 2006 Sep 13.

    PMID:
    16971434
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication.

    Argañaraz ER, Schindler M, Kirchhoff F, Cortes MJ, Lama J.

    J Biol Chem. 2003 Sep 5;278(36):33912-9. Epub 2003 Jun 19.

    PMID:
    12816953
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    Genotypic characterization of CRF01_AE env genes derived from human immunodeficiency virus type 1-infected patients residing in central Thailand.

    Utachee P, Jinnopat P, Isarangkura-Na-Ayuthaya P, de Silva UC, Nakamura S, Siripanyaphinyo U, Wichukchinda N, Tokunaga K, Yasunaga T, Sawanpanyalert P, Ikuta K, Auwanit W, Kameoka M.

    AIDS Res Hum Retroviruses. 2009 Feb;25(2):229-36.

    PMID:
    19108694
    [PubMed - indexed for MEDLINE]
    20.

    HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry.

    Tilton JC, Amrine-Madsen H, Miamidian JL, Kitrinos KM, Pfaff J, Demarest JF, Ray N, Jeffrey JL, Labranche CC, Doms RW.

    AIDS Res Hum Retroviruses. 2010 Jan;26(1):13-24.

    PMID:
    20055594
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk